Center for Scientific Review Notice of Closed Meetings, 5635-5637 [2018-02491]
Download as PDF
<![CDATA[
5635
Federal Register / Vol. 83, No. 27 / Thursday, February 8, 2018 / Notices
include homeless assistance purposes as
a permissible use under public health.
The Federal Asset and Transfer Act of
2016 (Pub. L. 114–287) streamlined the
Title V process bifurcating the
application process. Transfers are made
to transferees at little or no cost.
determine if institutions/organizations
are eligible to purchase, lease or use
property under the provisions of the
surplus real property program.
Responds are intermittent—only when
an eligible organization requests
acquisition of identified Federal surplus
real property.
We are requesting that the collection
be valid for three years.
Type of respondent: State and local
governments and non-profit institutions
use these applications to apply for
excess/surplus, underutilized/
unutilized and off-site government real
property. These applications are used to
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents
Type of respondent
Number
responses per
respondent
Average
burden per
response
(in hours)
Total
burden hours
Applications for surplus Federal real property .................................................
15
1
200
3,000
Total ..........................................................................................................
15
1
200
3,000
Terry S. Clark,
Office of the Secretary, Asst. Paperwork
Reduction Act Reports Clearance Officer.
[FR Doc. 2018–02477 Filed 2–7–18; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meetings
daltland on DSKBBV9HB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; R13 Conference Grants
Review.
Date: March 6, 2018.
Time: 1:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Room 1037, 6701
Democracy Boulevard, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Rahat Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, 6701 Democracy
Blvd., Rm. 1078, Bethesda, MD 20892, 301–
594–7319, khanr2@csr.nih.gov.
VerDate Sep<11>2014
17:18 Feb 07, 2018
Jkt 244001
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; TRND—Contract Review.
Date: March 7, 2018.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, One
Democracy Plaza, Room 1037, 6701
Democracy Boulevard, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, 6701 Democracy
Blvd., Rm. 1078, Bethesda, MD 20892, 301–
894–7319, khanr2@csr.nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Platform Delivery
Technologies for Nucleic Acid Therapeutics.
Date: March 29, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Room 1065, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Carol Lambert, Ph.D.,
Acting Director, Office of Scientific Review,
National Center for Advancing Translational
Sciences (NCATS), National Institutes of
Health, 6701 Democracy Blvd., Democracy 1,
Room 1076, Bethesda, MD 20892, 301–435–
0814, lambert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: February 1, 2018.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–02492 Filed 2–7–18; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Pain Mechanisms.
Date: March 1, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Integrative Neuroscience.
Date: March 1, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
E:\FR\FM\08FEN1.SGM
08FEN1
daltland on DSKBBV9HB2PROD with NOTICES
5636
Federal Register / Vol. 83, No. 27 / Thursday, February 8, 2018 / Notices
Contact Person: Jasenka Borzan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892–7814, 301–
435–1787, borzanj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Oncological Sciences.
Date: March 5–6, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Suites at the Chevy Chase Pavilion,
4300 Military Road NW, Washington, DC
20015.
Contact Person: Jian Cao, MD, Scientific
Review Officer, Center for Scientific Review,
6701 Rockledge Drive, Bethesda, MD 20892,
301–827–5902, caojn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Drugs of Abuse and Motivated Behavior.
Date: March 7–8, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, selmanom@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group; AIDSassociated Opportunistic Infections and
Cancer Study Section.
Date: March 8, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westgate Hotel, 1055 Second
Avenue, San Diego, CA 92101.
Contact Person: Eduardo A. Montalvo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Aging and Development, Auditory,
Vision and Low Vision Technologies.
Date: March 8–9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Torrance Redondo Beach Marriott,
3635 Fashion Way, Torrance, CA 90503.
Contact Person: Paek-Gyu Lee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4201,
MSC 7812, Bethesda, MD 20892, (301) 613–
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–AA–
18–007—Dynamic Neuroimmune
Interactions in the Transition from Normal
CNS Function to Disorders.
Date: March 8–9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
VerDate Sep<11>2014
17:18 Feb 07, 2018
Jkt 244001
Agenda: To review and evaluate grant
applications.
Place: The Alexandrian, Autograph
Collection, 480 King Street, Alexandria, VA
22314.
Contact Person: Afia Sultana, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Room 4189, Bethesda, MD
20892, (301) 827–7083, sultanaa@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Brain Disorders and Related
Neurosciences.
Date: March 8–9, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Vilen A. Movsesyan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M,
MSC 7806, Bethesda, MD 20892, 301–402–
7278, movsesyanv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Sensory and Motor
Neuroscience, Cognition and Perception.
Date: March 8–9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: Sharon S. Low, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104,
MSC 7846, Bethesda, MD 20892, 301–237–
1487, lowss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Physiology and Pathobiology of
Cardiovascular and Respiratory Systems.
Date: March 8–9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Katherine M. Malinda,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, 301–435–
0912, Katherine_Malinda@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group;
Behavioral and Social Science Approaches to
Preventing HIV/AIDS Study Section.
Date: March 8–9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Grand Hyatt Seattle, 721 Pine Street,
Seattle, WA 98101.
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
High Throughput Screening.
Date: March 8–9, 2018.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: David Filpula, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892, 301–435–
2902, filpuladr@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
044: Image-Guided Drug Delivery (R01).
Date: March 8, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Vocal Fold and Motor Disorders.
Date: March 8, 2018.
Time: 3:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Unja Hayes, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 301–
827–6830, unja.hayes@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Physiology and Pathobiology of
Cardiovascular and Respiratory Systems.
Date: March 9, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Agenda: Ritz-Carlton Pentagon City, 1250
South Hayes Street, Arlington, VA 22202.
Contact Person: Abdelouahab Aitouche,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4222,
MSC 7812, Bethesda, MD 20892, 301–435–
2365, aitouchea@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Understanding Structure and Function of
CNS Small Blood and Lymphatic Vessels:
Technology and Approach Innovation, Target
Identification, Biomarkers, and Disease
Mechanisms.
Date: March 9, 2018.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW, Washington, DC 20036.
E:\FR\FM\08FEN1.SGM
08FEN1
Federal Register / Vol. 83, No. 27 / Thursday, February 8, 2018 / Notices
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7846, Bethesda, MD 20892–7846, 301–
827–7238, zhaow@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 2, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–02491 Filed 2–7–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health (NIH)
National Institute of Mental Health
(NIMH) Notice of Meeting
daltland on DSKBBV9HB2PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of an
Interagency Autism Coordinating
Committee (IACC or Committee)
meeting.
The purpose of the IACC meeting is
to discuss business, agency updates, and
issues related to autism spectrum
disorder (ASD) research and services
activities. The meeting will be open to
the public and will be accessible by
webcast and conference call.
Name of Committee: Interagency Autism
Coordinating Committee.
Type of Meeting: Open Meeting.
Date: Thursday, April 19, 2018.
Time: 9:00 a.m. to 5:00 p.m. * Eastern Time
* Approximate end time.
Agenda: To discuss business, updates, and
issues related to ASD research and services
activities.
Place: Bethesda Marriott Hotel, 5151 Pooks
Hill Road, Bethesda, MD 20814.
Webcast Live: https://videocast.nih.gov.
Conference Call: Dial: 800–857–9791.
Access: Access code: 8959122.
Cost: The meeting is free and open to the
public.
Registration: A registration web link will
be posted on the IACC website
(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended to expedite
check-in. Seating in the meeting room is
limited to room capacity and on a first come,
first served basis. Onsite registration will also
be available.
Deadlines: Notification of intent to present
oral comments: Friday, April 6, 2018 by 5:00
p.m. ET, Submission of written/electronic
statement for oral comments: Tuesday, April
10, 2018 by 5:00 p.m. ET, Submission of
written comments: Tuesday, April 10, 2018
by 5:00 p.m. ET.
VerDate Sep<11>2014
17:18 Feb 07, 2018
Jkt 244001
For IACC Public Comment guidelines
please see: https://iacc.hhs.gov/meetings/
public-comments/guidelines/.
Access: Medical Center (Red Line Metro) in
combination with a 26-minute walk or short
taxi ride; parking available at the hotel for a
fee of our about ($16.00).
Contact Person: Ms. Angelice Mitrakas,
Office of Autism Research Coordination,
National Institute of Mental Health, NIH,
6001 Executive Boulevard, Room 6182A,
Bethesda, MD 20892–9669, Phone: 301–435–
9269, Email: IACCPublicInquiries@
mail.nih.gov.
Public Comments
Any member of the public interested
in presenting oral comments to the
IACC must notify the Contact Person
listed on this notice by 5:00 p.m. ET on
Friday, April 6, 2018 with their request
to present oral comments at the meeting,
and a written/electronic copy of the oral
presentation/statement must be
submitted by 5:00 p.m. ET on Tuesday,
April 10, 2018.
A limited number of slots for oral
comment are available, and in order to
ensure that as many different
individuals are able to present
throughout the year as possible, any
given individual only will be permitted
to present oral comments once per
calendar year (2018). Only one
representative of an organization will be
allowed to present oral comments in
any given meeting; other representatives
of the same group may provide written
comments. If the oral comment session
is full, individuals who could not be
accommodated are welcome to provide
written comments instead. Comments to
be read or presented in the meeting will
be assigned a 3–5 minute time slot
depending on the number of comments,
but a longer version may be submitted
in writing for the record. Commenters
going beyond their allotted time in the
meeting may be asked to conclude
immediately in order to allow other
comments and presentations to proceed
on schedule.
Any interested person may submit
written public comments to the IACC
prior to the meeting by emailing the
comments to IACCPublicInquiries@
mail.nih.gov or by submitting comments
at the web link: https://iacc.hhs.gov/
meetings/public-comments/submit/
index.jsp by 5:00 p.m. ET on Tuesday,
April 10, 2018. The comments should
include the name, address, telephone
number, and when applicable, the
business or professional affiliation of
the interested person. NIMH anticipates
written public comments received by
5:00 p.m. ET on Tuesday, April 10, 2018
will be presented to the Committee prior
to the meeting for the Committee’s
consideration. Any written comments
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
5637
received after the 5:00 p.m. ET, April
10, 2018 deadline through April 17,
2018 will be provided to the Committee
either before or after the meeting,
depending on the volume of comments
received and the time required to
process them in accordance with
privacy regulations and other applicable
Federal policies. All written public
comments and oral public comment
statements received by the deadlines for
both oral and written public comments
will be provided to the IACC for their
consideration and will become part of
the public record. Attachments of
copyrighted publications are not
permitted, but web links or citations for
any copyrighted works cited may be
provided.
In the 2016–2017 IACC Strategic Plan,
the IACC listed the ‘‘Spirit of
Collaboration’’ as one of its core values,
stating that, ‘‘We will treat others with
respect, listen with open minds to the
diverse views of people on the autism
spectrum and their families,
thoughtfully consider community input,
and foster discussions where
participants can comfortably where
participants can comfortably offer
opposing opinions.’’ In keeping with
this core value, the IACC and the NIMH
Office of Autism Research Coordination
(OARC) ask that members of the public
who provide public comments or
participate in meetings of the IACC also
seek to treat others with respect and
consideration in their communications
and actions, even when discussing
issues of genuine concern or
disagreement.
Remote Access
The meeting will be open to the
public through a conference call phone
number and webcast live on the
internet. Members of the public who
participate using the conference call
phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with
the webcast or conference call, please
send an email to IACCPublicInquiries@
mail.nih.gov or call 240–668–0302.
Individuals wishing to participate in
person or by using these electronic
services and who need special
assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a
request to the Contact Person listed on
this notice at least five days prior to the
meeting.
Security
Visitors will be asked to sign in and
show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) at the
E:\FR\FM\08FEN1.SGM
08FEN1
]]>Agencies
[Federal Register Volume 83, Number 27 (Thursday, February 8, 2018)]
[Notices]
[Pages 5635-5637]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02491]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Pain Mechanisms.
Date: March 1, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John Bishop, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Integrative Neuroscience.
Date: March 1, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
[[Page 5636]]
Contact Person: Jasenka Borzan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD
20892-7814, 301-435-1787, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Oncological Sciences.
Date: March 5-6, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Suites at the Chevy Chase Pavilion, 4300 Military Road
NW, Washington, DC 20015.
Contact Person: Jian Cao, MD, Scientific Review Officer, Center
for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892,
301-827-5902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Drugs of Abuse and Motivated Behavior.
Date: March 7-8, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD
20892, 301-435-1119, [email protected].
Name of Committee: AIDS and Related Research Integrated Review
Group; AIDS-associated Opportunistic Infections and Cancer Study
Section.
Date: March 8, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Westgate Hotel, 1055 Second Avenue, San Diego, CA
92101.
Contact Person: Eduardo A. Montalvo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108, MSC 7852, Bethesda, MD
20892, (301) 435-1168, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Aging and Development, Auditory, Vision and
Low Vision Technologies.
Date: March 8-9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Torrance Redondo Beach Marriott, 3635 Fashion Way,
Torrance, CA 90503.
Contact Person: Paek-Gyu Lee, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4201, MSC 7812, Bethesda, MD 20892, (301) 613-
2064, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-AA-18-007--Dynamic Neuroimmune Interactions in the
Transition from Normal CNS Function to Disorders.
Date: March 8-9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Alexandrian, Autograph Collection, 480 King Street,
Alexandria, VA 22314.
Contact Person: Afia Sultana, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, Room 4189, Bethesda, MD 20892, (301) 827-7083,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Brain Disorders and Related Neurosciences.
Date: March 8-9, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy
Chase, MD 20815.
Contact Person: Vilen A. Movsesyan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M, MSC 7806, Bethesda, MD
20892, 301-402-7278, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Sensory and Motor Neuroscience, Cognition and
Perception.
Date: March 8-9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 West Mission Bay Drive, San
Diego, CA 92109.
Contact Person: Sharon S. Low, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5104, MSC 7846, Bethesda, MD 20892, 301-237-
1487, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Physiology and Pathobiology of Cardiovascular
and Respiratory Systems.
Date: March 8-9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015.
Contact Person: Katherine M. Malinda, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD
20892, 301-435-0912, [email protected].
Name of Committee: AIDS and Related Research Integrated Review
Group; Behavioral and Social Science Approaches to Preventing HIV/
AIDS Study Section.
Date: March 8-9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Grand Hyatt Seattle, 721 Pine Street, Seattle, WA 98101.
Contact Person: Jose H. Guerrier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD
20892, 301-435-1137, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: High Throughput Screening.
Date: March 8-9, 2018.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: David Filpula, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD 20892, 301-435-
2902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-16-044: Image-Guided Drug Delivery (R01).
Date: March 8, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, 301-237-
9870, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Vocal Fold and Motor Disorders.
Date: March 8, 2018.
Time: 3:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Unja Hayes, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 301-827-6830,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Physiology and Pathobiology of Cardiovascular
and Respiratory Systems.
Date: March 9, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Agenda: Ritz-Carlton Pentagon City, 1250 South Hayes Street,
Arlington, VA 22202.
Contact Person: Abdelouahab Aitouche, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4222, MSC 7812, Bethesda, MD
20892, 301-435-2365, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: Understanding Structure and Function of CNS Small
Blood and Lymphatic Vessels: Technology and Approach Innovation,
Target Identification, Biomarkers, and Disease Mechanisms.
Date: March 9, 2018.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street NW, Washington, DC
20036.
[[Page 5637]]
Contact Person: Wei-Qin Zhao, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5181, MSC 7846, Bethesda, MD 20892-7846, 301-
827-7238, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 2, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-02491 Filed 2-7-18; 8:45 am]
BILLING CODE 4140-01-P
